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Abstract 
 
The study determined the histopathologic and hematologic effects of Arthrospira platensis 
and Moringa oleifera Lam., and their synergism on tumor-induced Sprague- Dawley rats. 
Induction of tumors was done through intraperitoneal administration of 1,2- 
dimethylhydrazine and 7,12-dimethylbenz[a]anthracene for four weeks. Readily available 
capsules and tablets of Spirulina and malunggay mixed with water were used to achieve 
the desired 50% and 75% concentration.   Intraperitoneal administration of the extracts 
and intravenous administration of 5-fluorouracil as the positive control treatment were 
done for two weeks post tumor induction. After treatment, representatives of each 
treatment groups were drawn blood and dissected for hematologic and histopathologic 
examination, respectively. Results show anti-tumor activity of all extracts in the liver in 
contrast to their ineffectiveness in the lungs. Furthermore, all but the 75% Spirulina extract 
were effective against gastric tumor development while both concentrations of Spirulina 
and its 75% concentration successfully countered development of tumors of the small 
intestine and large intestine, respectively. All of the extracts caused a general negative 
effect on the complete blood count. In conclusion, A. platensis proved to be the more 
effective against tumor development. 
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Introduction 
 
Cancer is described as a wild, unrestrained growth of abnormal cells that may 
originate in any body organ or tissue. They grow in a disorganized and uncontrolled pattern 
reproducing endlessly thus causing tumor, a pile up of abnormal cells, in the process. (1) 
Cancer has inflicted humans with records transcribed in papyrus since 1500 
B.C. in Egypt with eight cases of tumor affecting the breast until today in which it is the 
third leading cause of morbidity and mortality in the Philippines. (2-3) However, despite its 
lengthy existence and the use of modern technology in medicine, there is still no total and 
complete cure for cancer. 
Numerous studies have been conducted to treat various types of cancer; herbal 
medicine of which Arthrospira platensis and Moringa oleifera Lam. are grouped, is said 
to offer cures for different types of cancer. A. platensis commonly known as Spirulina, a 
filamentous cyanobacterium, is a widely known food supplement in the Philippines that 
gained recognition from several renowned institutions namely the World Health 
Organization (WHO) as the 21
st  
century best health food for human beings, the United 
Nations Educational, Scientific and Cultural Organization (UNESCO) as the most 
complete ideal food for tomorrow and the American Food and Drug Administration 
(FDA) as one of the best protein sources. (4) Spirulina is said to be rich in digestible 
proteins  and  other  phytochemicals,  and  studies  have  shown  its  role  in  controlling 
diabetes, cholesterol, coronary artery disease, wound healing and weight loss (5). In 
1988, a study evaluated the chemopreventive ability of Spirulina by proving that β- 
carotene and Spirulina-Dunaliella extracts inhibit carcinogenesis by preventing tumor 
development in hamster buccal pouch. (6) Later on, it was emphasized by the first human 
study examining the chemopreventive potential of Spirulina involving the species S. 
fusiformis tested in oral cancer. (7) On the other hand, Moringa oleifera Lam, locally 
known as malunggay, a common backyard plant in Filipino homes, has achieved popularity 
in mainstream scientific journals describing its nutritional and medicinal properties 
Primarily, it is rich in compounds containing the simple sugar, rhamnose. (8) It is plentiful 
in glucosinolates and isothiocyanates which both exhibit antibacterial and antifungal 
activity. (9) A research conducted in Bangladeshi medicine found through MTT assay 
that malunggay possess moderate cytotoxic activity on leukemia (HL-60 and CEM) and 
melanoma cell lines along with other extracts from identified specimens. (10) 
The primary goal of this paper is therefore to determine the effects of the extracts 
on the tumors induced in Sprague-Dawley rats and the changes in their complete blood 
counts. 
 
 
 
Methods 
 
Research Design 
Eight treatment groups including two control groups were used in the experiment. 
Two concentrations of Arthrospira platensis, Moringa oleifera Lam. and their synergism 
namely 50% and 75% and 5-fluorouracil were given. For each treatment, two trials were 
performed with two replicates each. Sixteen (16) male and sixteen (16) female Sprague- 
Dawley rats weighing 20-35 grams (g) were purchased from the Experimental Animal 
House Section, Bureau of Food and Drugs, Alabang, Muntinlupa City. 
    
Procurement and preparation of the different treatments 
Fifteen (15) tablets of Spirulina Vegetabs and twenty-five (25) capsules of 
Malunggay Capsules were procured from Carica Herbal Health Products, Inc. About 0.5 
g Spirulina tablets/5 ml water and 0.35 g malunggay capsules/5 ml water were considered 
to have a 100% concentration. Dilution formula was used to achieve the desired 50% and 
75% concentrations. Synergism treatments were prepared by mixing same concentration of 
the two extracts. The negative control group was not given any treatment while the positive 
control group was administered 5-fluorouracil. 
Acclimatization and maintenance of laboratory rats 
The main sites for the one-week acclimatization and maintenance of the Sprague- 
Dawley rats extracts were in the improvised facilities of the Besa’s residence. Rats caged 
as treatment groups were kept in good condition in a well-ventilated and well-lighted 
room  of  about  26-30°C.    The  cages  and  animal  facility  were  sanitized  regularly. 
Sufficient amount of food pellets and adequate amount of tap water were given to the rats 
twice daily. The cages were spacious enough to permit the rats to carry out normal 
behavior like exploring and grooming. Daily careful monitoring of the animals’ health 
condition was conducted. Dead rats were taken out of the cages immediately and were 
properly discarded. 
 
Induction   and   monitoring   of   tumors   and   administration   of   extracts   and 
chemotherapeutic drug 
Tumor  induction  and  administration  of  extracts  were  done  at  the  improvised 
laboratory facilities.  Tumors were introduced to the colon by intraperitoneal injections of 
30   mg   1,2-dimethylhydrazine   (DMH)/1   ml   saline/kg   body   weight   after   the 
acclimatization period every other day for three weeks. It was followed by a single 
intraperitoneal administration of 50 mg 7,12-dimethylbenz[a]anthracene (DMBA)/5 ml 
sesame oil/kg body weight at the age of 9 weeks. (11-12) After the initial induction, 
weekly palpation was conducted to ascertain the time of appearance, number, location 
and size of tumors. (12) Then, the extracts and treatment were administered through 
intraperitoneal injections. The 50% and 75% concentrations were given daily to treatment 
groups.   The   chemotherapeutic   drug,   5-   fluorouracil,   was   administered   through 
intravenous injection of about 100 mg/2 ml saline/kg body weight once a week. (13) The 
extracts and the drug were administered in the morning for two weeks. 
 
Histopathologic examination 
One  rat  per  treatment  group  manifesting  the  most  severe  signs  of  tumor 
development in terms of the behavior displayed and the morphological appearance of the 
organs was chosen for histopathologic examination regardless of its gender. The lungs, 
liver, stomach, small intestine and large intestine of each rat were initially processed 
observing the standard histologic technique of Bruce-Gregorios (14) at the laboratory room 
of Paolo Campos Hall (PCH), De La Salle University- Dasmariñas (DLSU-D), City of 
Dasmariñas, Cavite.  The samples were forwarded to the Histopathology Laboratory, The 
Research Institute for Tropical Medicine (RITM), Alabang, Metro Manila for more 
advanced processing. Histopathologic evaluation was conducted and was documented 
using a digital camera (Canon Digital IXUS 860 IS) at the Biology Research Laboratory, 
DLSU-D, City of Dasmariñas, Cavite. 
 
Hematologic examination 
A representative of each of the different groups were subjected to Complete 
Blood Count (CBC). The CBC analyses included the examination of hemoglobin (Hgb) 
level, red blood cell (RBC) count and white blood cell (WBC) count. Analyses were 
performed using Medic Drabkin’s reagent Cyanmethemoglobin Method, Hayem’s Solution 
Red Blood Cells Count, White Blood Cells Count Diluting Fluid and Wright- Giemsa Stain 
Schilling’s Differential Count. (15) The values obtained were compared to 
the standard hematologic data for Rattus norvegicus. The samples were processed at the 
Wellcare Clinics & Lab, City of Dasmariñas, Cavite. 
 
Termination of laboratory activities 
Lab  activities  were  terminated  properly  in  compliance  with  the  Bioethics 
Committee of the university on the second week of December. 
 
Data Analysis 
Developing tumors from the rats were measured using an ocular micrometer. 
Comparison of micrographs with images from Wheater’s Basic Histopathology was also 
done to assess changes on the tissues.  Validity of the histopathologic evaluations of the 
tissues   were   confirmed   by   a   pathologist   from   RITM,   Alabang,   Metro   Manila; 
hematologic data were analyzed through comparison with a standard reference value. 
(16) 
 
 
 
Results 
 
Histopathologic evaluation 
Examination  of  prepared  tissue  slides  before  and  after  treatments  indicated 
successful tumor induction by 1,2-DMH and 7,12-DMBA and halted development of 
cancer if not complete elimination, respectively. Table 1 shows the histopathologic 
findings in the lungs, liver, stomach, small intestine and large intestine of the treatment 
groups while Table 2 shows the frequency and size of the developing tumors found in the 
small intestine and large intestine. 
All of the treatment groups exhibited signs of tumor development in the lungs 
(Plate 1) in contrast to the absence of any abnormalities in the liver (Plate 2). The 
stomach (Plate 3) was almost clear from any histopathologic manifestations in contrary to 
the various abnormalities seen in the small and large intestines (Plates 4 and 5). 
Collapsed alveoli (A) along with extensive hemorrhage (H) were observed in the 
lungs of representative tissues of treatment groups except for the group that did not 
receive any treatment (Plate 1A-G); however, emphysema (E) was observed in the group 
wherein  no  treatment  was  applied  (Plate  1H).    On  the  other  hand,  the  liver  shows 
clearance from any hepatic abnormalities. However, inflammation (In) of some of the 
hepatic portal triads of the group that did not receive any treatment was observed (Plate 
2H). 
There is an apparent infiltration of lymphocytes (L) in the stomach (Plate 3A) in the 
group treated with 5-fluorouracil while the rest show no obvious abnormalities in the 
stomach. Remarkably, all of the treatment groups except those that were treated with 
75% Spirulina were observed to have abnormalities in the small intestine (Plate 4A-G). 
Observable anomalies were inflammations (In) and aggregations of lymphocytes (LA). 
Fibrous tissues such as fibromuscular (Fm) and fibrocollagenous (Fc) tissue were also 
formed. 
  
 
 
Plate 1. Effects of treatments on the histology of pulmonary tissue. Representative  hematoxylin-and-eosin 
(H & E) stained sections (x40). Collapsed alveoli (A), Hemorrhage (H) Emphysema (E)  A, T0 = positive 
control; B, T1= 50% Spirulina; C, T2 = 75% Spirulina; D, T3 = 50% malunggay; E, T4 = 75% malunggay; 
F, T5 = 50% synergism; G, T6 = 75% synergism; H, T7 = negative control 
 
 
 
 
Plate 2. Effects of treatments on the histology of hepatic tissue. Representative  hematoxylin-and-eosin  (H 
& E) stained sections (A, B, C, D, F, H x40; E, G x100). Inflammation  (In) Hepatic veins (V). A, T0 = 
positive  control; B, T1= 50% Spirulina;  C, T2  = 75% Spirulina;  D, T3  = 50% malunggay;  E, T4  = 75% 
malunggay; F, T5 = 50% synergism; G, T6 = 75% synergism; H, T7 = negative control 
Similar to that of the small intestine, lymphoid aggregates (LA) were present in 
the large intestine along with chronic inflammation (In). Fibromuscular tissue (Fm) 
formation was also evident. The normal architecture of the colon of most of the treatment 
groups was maintained though infiltration of lymphocytes begins to replace normal cells 
especially in the mucosa (M). Further distinct and mass-like aggregations of lymphocytes 
that are tumors (T) on the process of development are observed in the small intestine (Plate 
6A) of the group treated with 5-fluorouracil and large intestine (Plate 6B) of the group 
administered with 75% malunggay. 
Examining the effect in the lungs, rats administered with 50% Spirulina, both 
concentrations of malunggay, both synergism concentrations of Spirulina and malunggay 
and 5-fluorouracil were observed with atelectasis and extensive hemorrhage while those 
given with 75% Spirulina were seen with atelectasis along with chronic inflammation. Rats 
that were not given any treatments showed signs of chronic inflammation and emphysema. 
 
 
 
 
Plate 3. Effects of treatments on the histology of gastric tissue. Representative  hematoxylin-and-eosin  (H 
& E) stained sections (B, C, E, F, G, H x40; A, D x100). Surface epithelium  (SE), Muscularis  mucosae 
(MM). lymphocytes (L), Fibromuscular tissue (Fm). A, T0 = positive control; B, T1= 50% Spirulina; C, T2 
= 75% Spirulina; D, T3 = 50% malunggay; E, T4 = 75% malunggay; F, T5 = 50% synergism; G, T6 = 75% 
synergism; H, T7 = negative control 
 
Only the liver of the untreated rats showed signs of chronic inflammation in some 
of the portal triads; others were clear from any hepatic damage regardless of treatment. 
The stomach of rats that were administered with 75% Spirulina were observed 
with degenerated fibromuscular tissue while rats that were treated with 5-fluorouracil 
were seen to have lymphocytes infiltrating the tissue; others were clear from any gastric 
abnormalities. 
  
 
 
Plate  4.  Effects  of  treatments  on  the  histology  of  the  tissue  of  the  small  intestine.  Representative 
hematoxylin-and-eosin  (H & E) stained  sections  (A, B x40; C, D, E, F, G, H x100).. A, T0  = positive 
control; B, T1= 50% Spirulina; C, T2 = 75% Spirulina; D, T3 = 50% malunggay; E, T4 = 75% malunggay; 
F, T5 = 50% synergism; G, T6 = 75% synergism; H, T7 = negative control 
 
 
 
 
Plate 5. Effects of treatments on the histology of the colonic tissue. Representative hematoxylin-and-eosin 
(H & E) stained sections (D, E, F, G, H x40; A x100; B, C x400). Lymphoid  aggregates  (LA), Chronic 
inflammation  (In).  Fibromuscular  tissue  (Fm),  Mucosa  (M).    A,  T0  =  positive  control;  B,  T1=  50% 
Spirulina;  C,  T2  =  75%  Spirulina;  D,  T3  =  50%  malunggay;  E,  T4  =  75%  malunggay;  F,  T5  =  50% 
synergism; G, T6 = 75% synergism; H, T7 = negative control 
  
 
Plate  6. A. Small  intestine  with  Tumors  (T)  in the  group  treated  with  5-fluorouracil  (400x)  B. Large 
intestine with Tumors (T) in the group administered  with 75% malunggay  (40x). Hematoxylin-and-eosin 
(H & E) stained sections. 
 
Rats that were given 50% malunggay and both synergism concentrations were 
observed to have chronic inflammation and degenerated fibromuscular tissue in the small 
intestine while those which received 75% malunggay were seen with the same 
abnormalities in addition to the formation of lymphoid aggregates and granulation tissue. 
Rats treated with 50% and 75% Spirulina were observed with degenerated 
fibrocollagenous tissue while those which were administered with 5-fluorouracil showed 
chronic inflammation, granulation tissue formation, lymphocyte aggregation and 
fibrocollagenous tissue formation. Rats that did not receive any treatment were clear from 
any signs of tissue damage. 
Looking at the damage in the colon, rats which were treated with 75% malunggay 
and 5-fluorouracil showed intense signs of chronic inflammation and aggregation of 
lymphocytes  while  those  which  were  given  50%  Spirulina  manifested  the  same 
symptoms in addition to the presence of fibrocollagenous and fibroadipose tissue. Colons 
of rats that were given 50% malunggay and 50% synergism were chronically inflamed 
and  with  fibromuscular  tissue  while  those  administered  with  75%  Spirulina  were 
observed to have fibroadipose and fibromuscular tissue. Lymphoid aggregates were 
observed in rats that were given 75% synergism while those that did not receive any 
treatment were seen with chronically inflamed colon. 
The largest tumors were observed in the large intestine while the largest tumor 
was observed in the group treated with 5-fluorouracil as seen in Table 2. 
 
 
Hematologic evaluation 
Analysis of CBC such as elevated monocyte levels indicated successful tumor 
induction by 1,2- DMH and 7,12-DMBA. Table 3 and 4 shows the complete blood count of 
normal and treatment groups. 
CBC results from Table 3 showed that prior to the treatment period, the normal 
rat  exhibited  normal  blood  component  count  except  for  the  RBC  count;  after  the 
Chronic inflammation ++ ++ - ++ +++ ++ - + 
Lymphoid aggregates + +++ - - ++ - ++ - 
Degenerated fibrocollagenous tissue - + - - - - - - 
Degenerated fibroadipose tissue - + + - - - - - 
Degenerated fibromuscular tissue - - + + - + - - 
Developing tumor +++ ++ - - + - - - 
 
treatment period, decreased WBC count and elevated monocyte count were observed. 
Meanwhile, prior to the treatment period, the tumor-induced rat was known to have 
elevated monocyte count. Platelet counts of normal rats after the treatment period and 
tumor-induced rats before and after the treatment phase were observed to be much higher 
than normal. 
Comparison of the CBC of the treatment groups yielded several commonalities. A 
general trend of having lower than normal hematocrit, RBC count and lymphocytes and 
higher than normal segmenters was observed; eosinophil was also seen to be absent in most 
of the differential counts. 
 
 
Table 1. Histopathologic findings in the lungs, liver, stomach, small intestine and large 
intestine. 
 
Histopathologic characteristics*                                     Treatment Groups** 
 
T0             T1          T2        T3           T4           T5         T6         T7 
 
Lungs 
 
Atelectasis ++ + + + + + ++ - 
Chronic inflammation - - + - - - - ++ 
Hemorrhage + ++ - ++ ++ + + - 
Emphysema - - - - - - - + 
Liver 
Chronic inflammation                                      -           -         -        -          -          -        -        + 
 
Stomach 
Degenerated fibromuscular tissue                 -           -         +        -          -          -        -        - 
Lymphocyte infiltration                                  +           -         -        -          -          -        -        - 
 
 
Small Intestine 
Chronic inflammation ++ -         -      ++        + ++      +      - 
Granulation tissue formation to + -         -        -         + -        -      - 
lymphoid aggregates          
Degenerated fibrocollagenous tissue  + + + - - - - - 
Degenerated fibromuscular tissue  - - - + + + + - 
Developing tumor  ++ - - - + - - - 
 
Large Intestine 
 
 
 
 
 
 
 
 
* - sign means absence; + sign means presence of the characteristic;  more + signs indicate severity of damage 
**T0 = positive  control, T1= 50% Spirulina;  T2  = 75% Spirulina;  T3  = 50% malunggay;  T4  = 75% malunggay;  T5  = 
50% synergism; T6 = 75% synergism; T7 = negative control 
Segmenters 28 15 15 25 10-30 
Lymphocytes 65 78 77 70 65-85 
            Eosinophils 2 1 3 2 0-6 
Platelet count 2.07 x 1013 6.02 x 1013 + 7.74 x 1013 + 5.81 x 1013 + 1.50-4.60 x 1013 
(cells/L)      
 
Physical and behavioral changes 
Certain physical and behavioral changes were seen in the tumor-induced rats. All 
were observed to have uncoordinated body movements, loss of control of urination, 
periodic gnawing of cage wires and clay pots, gradual thinning and loss of fur, untidy 
coat and popping eyes. 
 
 
 
Table 2. Size (µ)  and frequency (%) of developing tumors in the different organs of 
treatment groups. 
 
Treatment Groups*                                                                           Organ 
Small Intestine 
µ 
Small Intestine 
N (%) 
Large 
Intestine 
µ 
Large Intestine 
N (%) 
 
 
T0 500 3 (75) 3000 2 (22.22) 
 375  3000  
 250    
T1 ⎯  0 (0) 750 4 (44.44) 
   1125  
   1000  
   750  
T2 ⎯  0 (0) ⎯  0 (0) 
T3 ⎯  0 (0) ⎯  0 (0) 
T4 ⎯  0 (0) 312.5 3 (33.33) 
   500  
   500  
T5 ⎯  0 (0) ⎯  0 (0) 
T6 300 1 (25) ⎯  0 (0) 
T7 ⎯  0 (0) ⎯  0 (0) 
* T0 = positive control, T1= 50% Spirulina; T2 = 75% Spirulina; T3 = 50% malunggay; T4 = 75% malunggay; T5 = 50% 
synergism; T6 = 75% synergism; T7 = negative control 
 
 
Table 3. Complete blood count of normal and tumor-induced rats before and after the 
treatment period. 
 
Blood Component* Normal Rat (Pre) Normal Rat (Post) Tumor-Induced Tumor-Induced Normal Values 
   Rat (Pre) Rat (Post)  
Hemoglobin (g/dL) 14.2 14.3 14.3 12.6 11-19.2 
 
Hematocrit (%) 42 43 43 38 36-54 
WBC (cells/L) 8.4 x 109 5.3 x 109 + 8.7 x 109 6.8 x 109 6.6-12.6 x 109 
RBC (cells/L) 6.52 x 1012 + 8.48 x 1012 7.61 x 1012 7.34 x 1012 6.76-9.75 x 1012 
 
Differential count (%) 
 
 
Monocytes                                            5                                    6
+                                                              
6
+                                                             
3                                   0-5 
 
 
 
*Values per parameter with 
+ 
indicate deviation from the normal values. 
Table 4. Complete blood count of treatment groups. 
 
Blood Component*   Treatment Groups** 
 
T2                                                   T3                                                   T4                                        Normal  T0 T1 
      Values 
Hemoglobin (g/dL) 14.3 6.0 + 11.0 9.0+ 8.6+ 11-19.2 
 
Hematocrit (%) 
 
43 
 
18 + 
 
33 + 
 
27 + 
 
26 + 
 
36-54 
WBC (cells/L) 5.3 x 109 + 1.1 x 109 + 7.1 x 109 7.1 x 109 7.3 x 109 6.6-12.6 x109 
RBC (cells/L) 8.48 x 1012 3.42 x 1012 + 6.66 x 1012 + 5.22 x 1012 + 5.14 x 1012 + 6.76-9.75 x1012 
 
Differential count (%) 
Segmenters 
 
15 
 
31 
+ 
 
31 
+ 
 
39 
+ 
 
87 
+ 
 
10-30 
Lymphocytes 78 61 + 59 + 60 + 13 + 65-85 
Monocytes 6 + 8 + 10 + 1 0 0-5 
Eosinophils 1 0 0 0 0 0-6 
Platelet count 6.02 x 1013 + 6.5 x 1012 + 3.59 x 1013 6.89 x 1013 + 2.75 x 1013 1.50-4.60 x 1013 
(cells/mL)       
*Values per parameter with 
+ 
indicate deviation from the normal values; 
**T0 = positive control, T1= 50% Spirulina, T2 = 75% Spirulina, T3 = 50% malunggay, T4 = 75% malunggay, 
 
 
Discussion 
 
In the Philippines, cancer is the third leading cause of morbidity and mortality. (3) 
At present, there is still no complete and cost-efficient cure that poses no detrimental side 
effects. 
Examination of tissues indicates considerable anti-cancer action of administered 
extracts. Observation of abnormalities in the normal rat wherein no tumor was induced is 
suggestive as general symptoms of many diseases, including cancer. Abnormalities seen 
in the group wherein 5-fluorouracil was used as treatment may suggest that rats, while of 
the same species, may have different levels of physiologic and immunologic responses to 
completely eradicate tumor and its signs of development; same explanations also account 
for abnormal blood counts seen on the normal rat and those treated with 5-fluorouracil. 
Atelectasis of the lungs as observed in the treatment groups is a condition wherein 
the alveoli collapses with decreased pulmonary air capacity. (17) One possible cause of 
such is the obstruction of the main bronchus due to a developing tumor. (18) This was 
evident in all but the group that didn’t receive any treatment which may suggest that the 
extracts did not have any effect on alleviating this condition. 
However, only the untreated group showed signs of emphysema, the abnormal 
enlargement of the air spaces far from the terminal bronchiole. Recent studies have 
shown to link emphysema and cancer through activation of pleiomorphic adenoma gene- 
like 2 (PLAGL2). (19) On the other hand, hemorrhage that may be brought about by the 
developing tumor’s injury to the capillary walls was observed in all but two groups that 
received 75% malunggay and no treatment. Such was also accompanied by thickening of 
the alveolar septa. (17) Then, clearance of the hepatic tissues of the various treatment 
groups from any abnormalities may suggest a preventive or cytotoxic activity of the 
extracts to the developing tumors. 
Lymphoid aggregates in the gastric lamina propria are suggestive of a developing 
cancer such as lymphoma, the second most common malignant tumor of the said organ. 
(20) The same formations in the colon are indicative of an impending colorectal disease 
such as carcinoma, diverticular disease, Crohn’s disease or ulcerative colitis. (21) 
However, formation of fibrous tissues such as fibroadipose, fibromuscular and 
fibrocollagenous tissue are signs of repair mechanism of the tissue to counter the damage 
of a tumor; this is exemplified by the reparative function of fibroblasts to replace the 
damaged tissue through deposition of collagen. (22) 
A fully developed tumor was not observed in any of the tissue sample. However, 
lymphoid aggregates that formed distinct masses and intervened with the normal 
architecture of the tissue were counted as developing tumors. 
Altogether, absence of a fully developed tumor may suggest therapeutic action of 
the extracts. Such anti-cancerous effects may be attributed to the phyocyanin and benzyl 
isothiocyanate found in Spirulina and malunggay, respectively. (23-24) 
Tumor-induced  negative  control  rats  showed  elevated  monocyte  levels  and 
platelet count prior to treatment; such occurrence can be attributed to the response in the 
development of tumor wherein monocytes will eventually differentiate into macrophages to 
produce tumor necrosis factor alpha (TNF- α), a cytokine that causes disintegration of 
tumor cells. (25) Such production will then cause the liver to synthesize acute-phase 
proteins that play a role in inflammatory response, a phenomenon associated with cancer 
development; (26) such inflammatory conditions were observed in various organs. 
Meanwhile, increased platelet counts observed on tumor-induced rats may be indicative 
of tumor development. Various stimuli such as inflammation, tumor and cancer causes 
secondary  or  reactive  thrombocytosis,  a  phenomenon  in  which  platelets  increase  in 
number as a response. (27) Finally, the increased WBC of tumor-induced rat relative to that 
of the normal rat reflects the immunologic condition of the tumor-induced rat. 
A  general  trend  of  having  decreased  hematocrit  levels,  RBC  count  and 
lymphocyte count, increase in segmenters and absence of eosinophils were observed in 
treatment groups administered with extracts. Decrease in hematocrit levels which is a 
consequence of a low RBC count can be an outcome of loss of blood such as in a 
bleeding colon cancer (28) or a side effect that damages the bone marrow thus impeding 
production of RBC and lymphocytes as well. (29) Meanwhile, increase in segmenters or 
neutrophils are indicative of inflammation and bone marrow disorders such as leukemia; 
absence or extremely low eosinophil count can be attributed to tumor growth attenuation. 
(30) On the contrary, the decrease in WBC observed is linked with reduced ability to 
ward of foreign bodies or formation which may indicate the development of tumor as 
seen in groups treated with 5-fluorouracil and 50% Spirulina. (29) Decreased hemoglobin 
is then related with decreased RBC count because of the physiological association of the 
two parameters while decreased platelet count is a causative factor of hemorrhage 
observed. 
The physical changes such as hair loss and behavioral changes observed may be 
attributed to body weakness, uneasiness, stress and pain caused by the developing tumor. 
(17) Gnawing of non-food materials such as claypots and cage wires and squeaking are a 
result of acute pain and stress brought about by tumor development; (17, 31) 
aggressiveness towards other rats, another tumor-related manifestation, (32) was also 
observed during the course of induction. Studies also associate tumor development in 
depressive-like behavior. (33) 
Based on data interpretation and analysis, the present study concludes the 
effectiveness  of  both  extracts  against  tumor  development.  However,  Arthrospira 
platensis  is  relatively  more  effective  in  countering  the  manifestations  of  tumor 
development. Overall, the extracts were ineffective against tumor development in the 
lungs in contrast to their effectiveness in hepatic tumor development. In the stomach, all 
of the extracts except A. platensis at 75% concentration were effective while in the small 
intestine, both concentrations of A. platensis were relatively the most effective. Then, A. 
platensis at 75% was relatively the most effective against colonic tumor development. 
Meanwhile, a general trend of the CBC suggests tumor growth and attenuation at the 
same time. 
It is worth recommending to use and place more replicates in a more controlled 
environment  to  lessen  other  influential  factors;  a  longer  induction  period  should  be 
observed for more extensive tumor development. More sophisticated procedures such as 
methyl thiazol tetrazolium (MTT) assay and molecular examination of active components 
should also be used to gain deeper understanding of the extracts’ cytotoxic activity. 
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